Literature DB >> 16344962

Development of water-soluble metallofullerenes as X-ray contrast media.

Akihiko Miyamoto1, Haruya Okimoto, Hisanori Shinohara, Yuta Shibamoto.   

Abstract

Fullerenes are a new carbonic allotrope having a cage structure. We investigated whether fullerenes containing one or two atoms of heavy metals could be an X-ray contrast material with little adverse effects. One or two atoms of dysprosium (Dy), erbium (Er), gadolinium (Gd), europium (Eu) and lutetium (Lu) were encapsulated into fullerene (C(82)), which was synthesized as a polyhydroxyl form (e.g., Gd@C(82)(OH)n, n=40, Gd - fullerenols). They were dissolved in water at maximum soluble concentrations and subjected to CT number analysis. The CT numbers of the solutions were measured using a 4- or 16-row multidetector CT scanner. The CT number of the water-soluble metallofullerenes were 56.0 HU for Dy@C(82)(OH)(40), 111.5 HU for Er@C(82)(OH)(40), 58.4 HU for Gd@C(82)(OH)(40), 100.9 HU for Eu@C(82)(OH)(40) and 23.3 HU for Lu(2)@C(82)(OH)(40). The CT numbers of the metallofullerenes investigated in the present study were not high enough to be used in the clinic in place of iodinated contrast materials. However, if nanotechnology progresses in the near future, it may prove to have a possibility as an X-ray contrast material.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344962     DOI: 10.1007/s00330-005-0064-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  12 in total

1.  Atomic Force Microscope Studies on Condensation of Plasmid DNA with Functionalized Fullerenes This research was supported by Grant-in-Aid for Specially Promoted Research from Ministry of Education, Culture, Sports, Science, and Technology.

Authors:  Hiroyuki Isobe; Sho Sugiyama; Yasuhiro Iwasawa; Eiichi Nakamura
Journal:  Angew Chem Int Ed Engl       Date:  2001-09-17       Impact factor: 15.336

Review 2.  Contrast media: interactions with other drugs and clinical tests.

Authors:  Sameh K Morcos; Henrik S Thomsen; C M Exley
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

3.  Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.

Authors:  H Katayama; K Yamaguchi; T Kozuka; T Takashima; P Seez; K Matsuura
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

4.  Lanthanoid endohedral metallofullerenols for MRI contrast agents.

Authors:  Haruhito Kato; Yoko Kanazawa; Masafumi Okumura; Atsushi Taninaka; Takashi Yokawa; Hisanori Shinohara
Journal:  J Am Chem Soc       Date:  2003-04-09       Impact factor: 15.419

5.  In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity.

Authors:  S Yamago; H Tokuyama; E Nakamura; K Kikuchi; S Kananishi; K Sueki; H Nakahara; S Enomoto; F Ambe
Journal:  Chem Biol       Date:  1995-06

Review 6.  Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

Authors:  S K Morcos; H S Thomsen; J A Webb
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

7.  Syntheses and biological evaluations of alpha-D-mannosyl [60]fullerenols.

Authors:  H Kato; A Yashiro; A Mizuno; Y Nishida; K Kobayashi; H Shinohara
Journal:  Bioorg Med Chem Lett       Date:  2001-11-19       Impact factor: 2.823

Review 8.  In which patients should serum creatinine be measured before iodinated contrast medium administration?

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

9.  Results of the safety and efficacy of iobitridol in more than 61,000 patients.

Authors:  J Petersein; C R Peters; M Wolf; B Hamm
Journal:  Eur Radiol       Date:  2002-10-08       Impact factor: 5.315

10.  Effect of iodinated contrast media on thyroid function in adults.

Authors:  Aart J van der Molen; Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-02-28       Impact factor: 5.315

View more
  5 in total

1.  Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.

Authors:  Jie Meng; Dong-liang Wang; Paul C Wang; Lee Jia; Chunying Chen; Xing-Jie Liang
Journal:  J Nanosci Nanotechnol       Date:  2010-12

2.  AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging.

Authors:  Bulent Aydogan; Ji Li; Tijana Rajh; Ahmed Chaudhary; Steven J Chmura; Charles Pelizzari; Christian Wietholt; Metin Kurtoglu; Peter Redmond
Journal:  Mol Imaging Biol       Date:  2010-10       Impact factor: 3.488

3.  Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor.

Authors:  Ying Liu; Chunying Chen; Pengxu Qian; Xuefei Lu; Baoyun Sun; Xiao Zhang; Liming Wang; Xingfa Gao; Han Li; Zhiyun Chen; Jinglong Tang; Weijie Zhang; Jinquan Dong; Ru Bai; Peter E Lobie; Qingfa Wu; Suling Liu; Huafeng Zhang; Feng Zhao; Max S Wicha; Tao Zhu; Yuliang Zhao
Journal:  Nat Commun       Date:  2015-01-23       Impact factor: 14.919

4.  Suppression of synaptic plasticity by fullerenol in rat hippocampus in vitro.

Authors:  Xin-Xing Wang; Ying-Ying Zha; Bo Yang; Lin Chen; Ming Wang
Journal:  Int J Nanomedicine       Date:  2016-09-28

5.  A platform for specific delivery of lanthanide-scandium mixed-metal cluster fullerenes into target cells.

Authors:  Anna Svitova; Klaus Braun; Alexey A Popov; Lothar Dunsch
Journal:  ChemistryOpen       Date:  2012-09-28       Impact factor: 2.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.